The RPS4 antibody is a specialized immunological tool designed to detect and study the ribosomal protein S4 (RPS4) or its homologs. In plants, RPS4 is a critical component of immune receptor complexes, while in humans, its homolog RPS4X (ribosomal protein S4 X-linked) is essential for ribosome assembly and protein synthesis. This antibody enables researchers to investigate RPS4/RPS4X localization, interactions, and functional roles in diverse biological contexts.
In plants, RPS4 functions as part of a two-component immune receptor complex with RRS1, recognizing pathogen effectors like AvrRps4 and PopP2. Key findings include:
Immune Complex Formation: RPS4 and RRS1 form a hetero-oligomeric complex primarily localized in the nucleus. RPS4 does not self-associate without RRS1 .
Effector Recognition: The complex detects effectors via the RRS1 WRKY domain, triggering conformational changes that activate defense signaling. The TIR domains of RPS4 and RRS1 interact to modulate defense activation .
Downstream Signaling: RPS4/RRS1 associates with the EDS1/PAD4 complex, critical for defense gene activation. This interaction is required for both pre- and post-activation states .
In humans and animals, RPS4X (a homolog of plant RPS4) is a core component of the 40S ribosomal subunit, critical for translation.
Ribosome Assembly: RPS4X binds to 18S rRNA, facilitating the assembly of the 40S subunit .
Cell Differentiation: Overexpression of RPS4 in Dictyostelium enhances differentiation, while antisense RNA disrupts this process .
Disease Association: Dysregulation of RPS4X is linked to ribosomopathies and cancers, as ribosomal stress impacts cell proliferation .
Suppression of Autoimmunity: RRS1 stabilizes RPS4 and prevents effector-independent defense activation. Mutations in RPS4’s P-loop motif disrupt RRS1 SLH1-mediated immunity .
Pathogen-Specific Signaling: RPS4/RRS1 and RRS1B/RPS4B are paralogous pairs that independently activate defense genes upon AvrRps4 recognition .
KEGG: ath:ArthCp024
STRING: 3702.ATCG00380.1
RPS4 (Resistance to Pseudomonas Syringae 4) is a nucleotide-binding domain and leucine-rich repeat (NLR) immune receptor protein in plants. It functions as part of a paired immune receptor complex with RRS1 to recognize specific pathogen effector proteins, particularly AvrRps4 from Pseudomonas syringae. This recognition triggers immune responses that restrict pathogen growth. The RPS4/RRS1 complex associates with immune regulators EDS1/PAD4 or EDS1/SAG101 during the defense activation process. In Arabidopsis thaliana, RPS4 is encoded by the gene At5g45250 and has a molecular weight of approximately 137.7 kDa .
The RPS4/RRS1 complex forms a nuclear-localized immune receptor complex that recognizes bacterial effectors such as AvrRps4 and PopP2. Upon effector recognition, the complex undergoes conformational changes rather than dissociation. Importantly, RPS4 protein alone does not self-associate in the absence of RRS1, and RPS4 autoimmunity is suppressed when co-expressed with RRS1. The complex maintains its association with EDS1/PAD4 both before and after activation, suggesting that recognition of effectors provokes conformational changes within the complex rather than disrupting it .
Currently, researchers have access to polyclonal antibodies raised against RPS4. For example, a rabbit polyclonal antibody (AS16 3992) has been developed using a KLH-conjugated synthetic peptide derived from Arabidopsis thaliana RPS4 sequence (UniProt: Q9XGM3, TAIR: At5g45250). This antibody is immunogen affinity purified and specifically designed to avoid cross-reactivity with the RPS4B isoform. It has confirmed reactivity with Arabidopsis thaliana recombinant RPS4 but does not react with proteins from Nicotiana benthamiana .
For Western blot applications using RPS4 antibodies, the recommended dilution is 1:2000 to 1:4000. The antibody can detect the expected molecular weight of 137.7 kDa for RPS4 protein. For optimal results, researchers should:
Properly reconstitute lyophilized antibody with 50 μl of sterile water
Store at -20°C and prepare aliquots to avoid repeated freeze-thaw cycles
Spin tubes briefly before opening to prevent loss of material adhering to caps or sides
Include appropriate controls, such as samples from rps4 mutant plants or recombinant RPS4 protein
To validate RPS4 antibody specificity, implement the following methodological approach:
Include positive controls (recombinant RPS4 protein) and negative controls (rps4 mutant plant extracts) in your experiments
Perform peptide competition assays by pre-incubating the antibody with the immunizing peptide
Compare detection patterns in different plant tissues known to express varying levels of RPS4
Verify protein size corresponds to the expected 137.7 kDa for the full-length RPS4 protein
If possible, use immunoprecipitation followed by mass spectrometry to confirm antibody target
Test reactivity in both native and denatured conditions to determine conformational specificity
For optimal detection of RPS4 in plant tissues, consider these methodological approaches:
Nuclear extraction protocol: Since RPS4 is predominantly nuclear-localized when in complex with RRS1, nuclear extraction protocols can enrich for the protein. This involves tissue homogenization in nuclear isolation buffer, filtration, and differential centrifugation.
Total protein extraction: Use buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, and protease inhibitor cocktail.
Protein stabilization: As RPS4 protein stability is enhanced by RRS1, consider co-immunoprecipitation approaches when studying the native complex.
Fractionation approach: For more detailed studies, perform cellular fractionation to separately examine cytosolic and nuclear pools of RPS4, as its localization is dynamically regulated and affected by complex formation with RRS1 .
To study the dynamics of the RPS4/RRS1 immune complex, RPS4 antibodies can be utilized in several sophisticated approaches:
Co-immunoprecipitation (Co-IP): Use RPS4 antibodies to pull down the entire complex and analyze interacting partners before and after pathogen effector treatment. This approach has revealed that RPS4 association with EDS1 is nuclear-localized when RRS1 is present, but cytoplasmic in the absence of RRS1 .
Chromatin immunoprecipitation (ChIP): Since the complex contains the WRKY DNA-binding domain of RRS1, RPS4 antibodies can help study chromatin association of the complex following sequential IP approaches.
Proximity-based labeling: Combine RPS4 antibodies with techniques like BioID or APEX to identify transiently interacting proteins in the vicinity of the complex.
Live-cell imaging with antibody fragments: Use Fab fragments derived from RPS4 antibodies for real-time imaging of complex dynamics during immune activation.
FRET-FLIM analysis: Combine fluorescently-tagged RPS4 antibodies with RRS1-specific antibodies to monitor conformational changes in the complex during effector recognition .
To distinguish between different binding modes of RPS4 with its partners, researchers can employ:
Domain-specific antibodies: Develop antibodies targeting specific domains of RPS4 to monitor domain accessibility changes in different binding modes.
Biophysics-informed modeling: Similar to approaches used for antibody specificity analysis, computational models can predict different binding modes based on experimental selection data. This involves identifying distinct binding signatures for each interaction partner .
Hydrogen-deuterium exchange mass spectrometry (HDX-MS): This technique can reveal which regions of RPS4 become protected or exposed upon binding to different partners.
Site-directed mutagenesis combined with antibody epitope mapping: Systematically mutate potential interface residues and use antibodies to detect changes in binding patterns.
Single-molecule FRET: Monitor distance changes between labeled components to distinguish different binding conformations .
The P-loop motif of RPS4 plays a critical role in its function, and mutations in this region have several consequences:
Multiple bands or unexpected molecular weights when using RPS4 antibodies could result from several factors:
Alternative splicing: RPS4 may have splice variants that result in proteins of different molecular weights.
Post-translational modifications: Phosphorylation, ubiquitination, or other modifications can alter the apparent molecular weight of RPS4.
Protein degradation: RPS4 is less stable in the absence of RRS1, with approximately 3.5 times less RPS4 protein detected when expressed without RRS1. This instability may lead to degradation products that appear as lower molecular weight bands .
Cross-reactivity: Despite efforts to ensure specificity, antibodies may cross-react with related proteins like other NLR family members.
Protein complexes: Incomplete sample denaturation may result in detection of RPS4 in complexes with other proteins, resulting in higher molecular weight bands.
Experimental artifacts: Insufficient sample reduction or incomplete transfer during Western blotting can cause unexpected banding patterns .
To address cross-reactivity issues when studying RPS4 across plant species:
Perform sequence alignment analysis: Align the epitope sequence with potential homologs in the target species to predict cross-reactivity.
Use peptide competition assays: Pre-incubate the antibody with the immunizing peptide to verify specific binding.
Include appropriate controls: Always include samples from the species in which the antibody was developed (e.g., Arabidopsis thaliana) alongside your experimental species.
Consider raising custom antibodies: Design peptides based on conserved regions if studying RPS4 across multiple species.
Validate with alternative methods: Confirm antibody results with techniques like mass spectrometry or gene expression analysis.
Be aware of known limitations: For example, the AS16 3992 antibody does not react with Nicotiana benthamiana proteins, limiting its use in this model system .
When studying RPS4-effector interactions, include these essential controls:
Genetic controls:
Wild-type plants
rps4 single mutants
rrs1 single mutants
rps4/rrs1 double mutants
eds1 mutants (as EDS1 is required for RPS4/RRS1-mediated immunity)
Effector controls:
Inactive effector variants (e.g., PopP2 C321A)
Nuclear-localized effector (NLS-tagged)
Nuclear-excluded effector (NES-tagged)
Antibody controls:
IgG isotype control for immunoprecipitation
Pre-immune serum control
Secondary antibody-only control for immunofluorescence
Experimental controls:
Computational approaches offer promising avenues for improving RPS4 antibody design:
Biophysics-informed modeling: Similar to approaches described in antibody specificity research, models can be developed that associate distinct binding modes with specific ligands. These models can predict antibody variants with improved specificity profiles for RPS4 .
Epitope prediction and optimization: Computational tools can identify optimal epitopes unique to RPS4 that are both immunogenic and accessible in the native protein conformation.
Structure-based design: As structural information about RPS4 becomes available, structure-based computational approaches can design antibodies that target specific conformational states of RPS4.
Machine learning approaches: Training algorithms on existing antibody-antigen interactions can help predict optimal antibody sequences for RPS4 recognition.
High-throughput virtual screening: Computational screening of antibody libraries can identify candidates with desired properties before experimental validation .
Emerging techniques that could enhance RPS4 antibody applications include:
Single-domain antibodies (nanobodies): These smaller antibody fragments could access epitopes hidden in the RPS4/RRS1 complex that conventional antibodies cannot reach.
Proximity-dependent labeling: Combining RPS4 antibodies with enzymatic tags for BioID or APEX proximity labeling could reveal transient interaction partners during immune activation.
Antibody-guided CRISPR systems: RPS4 antibodies could be used to guide CRISPR-based systems for targeted modification of RPS4 or its interaction partners.
Microfluidic antibody profiling: High-throughput microfluidic systems could rapidly assess antibody specificity across multiple conditions and tissues.
Conformational state-specific antibodies: Developing antibodies that specifically recognize the active or inactive states of RPS4 could provide new insights into the activation mechanism .
RPS4 antibodies can significantly advance our understanding of plant immune system evolution through:
Comparative immunology: Using RPS4 antibodies across different plant species to track conservation and divergence of the immune receptor.
Coevolutionary analysis: Combining antibody-based detection of RPS4 with studies of pathogen effector evolution to understand the molecular arms race.
Structural conservation mapping: Using epitope mapping with RPS4 antibodies to identify structurally conserved regions across diverse plant species.
Functional domain analysis: Antibodies targeting specific domains can reveal which regions are evolutionarily constrained versus those that are rapidly evolving.
Ancestral protein reconstruction: RPS4 antibodies could help validate computationally reconstructed ancestral immune receptors by confirming structural and functional predictions .